Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 4/20 | 0.70 |
| ▸ | CYP1B1 | Q16678 | 4/20 | 0.70 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.65 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | CTNNB1 | P35222 | 5/20 | 0.47 |
| ▸ | WNT3A | P56704 | 5/20 | 0.47 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | NQO1 | P15559 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ovalitenone SCHEMBL29598773 | 0.82 | CYP1A1 (1.00) | CYP1A1CYP1B1CYP1A2MEN1KMT2A | |
| SCHEMBL29598875 | 0.80 | CYP1A1 (0.57) | CYP1A1CYP1B1CYP1A2MEN1KMT2A | |
| SCHEMBL900826 | 0.79 | CYP1A1 (1.00) | CYP1A1CYP1B1CYP1A2MEN1KMT2A | |
| SCHEMBL29664148 | 0.79 | CYP1A1 (1.00) | CYP1A1CYP1B1CYP1A2MEN1KMT2A | |
| SCHEMBL2237626 | 0.74 | MEN1 (0.76) | MEN1KMT2ACTNNB1WNT3AMAPT | |
| SCHEMBL29458253 | 0.74 | MEN1 (0.76) | MEN1KMT2ACTNNB1WNT3AMAPT | |
| SCHEMBL26624014 | 0.74 | KMT2A (0.72) | MEN1KMT2ACTNNB1WNT3AMAPT | |
| SCHEMBL13516462 | 0.72 | MEN1 (1.00) | MEN1KMT2ACTNNB1WNT3ANPC1 | |
| SCHEMBL2045384 | 0.71 | CYP1A1 (0.63) | CYP1A1CYP1B1CYP1A2ABCB1MAPT | |
| SCHEMBL17055815 | 0.70 | MEN1 (0.74) | MEN1KMT2ACTNNB1WNT3ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12610971-B2 | Pongamia compositions, methods of preparing and analyzing thereof, and uses thereof | TerViva BioEnergy, Inc. (US) | 2026-04-28 | — | — | US | claimed |
| US-12610971-B2 | Pongamia compositions, methods of preparing and analyzing thereof, and uses thereof | TerViva BioEnergy, Inc. (US) | 2026-04-28 | — | — | US | disclosed |
| US-12052994-B2 | Methods for controlling black sigatoka in bananas using pongamia oil and formulations thereof | Terviva, Inc. (US) | 2024-08-06 | — | — | US | disclosed |
| CN-116036646-A | Extraction process and extraction device for smilax glabra rhizome active ingredient capable of inhibiting xanthine oxidase | 湖州市食品药品检验研究院(湖州市药品和医疗器械不良反应监测中心、湖州市医疗器械监督检验中心、湖州市食品认证审评和粮油质量监测中心) | 2023-05-02 | — | — | CN | disclosed |
| US-20220369662-A1 | EDIBLE PONGAMIA COMPOSITIONS, AND METHODS OF PREPARING AND USING THEREOF | Terviva, Inc. (US) | 2022-11-24 | — | — | US | disclosed |
| EP-4037491-A1 | EDIBLE PONGAMIA COMPOSITIONS, AND METHODS OF PREPARING AND USING THEREOF | TerViva, Inc. (US) | 2022-08-10 | — | — | EP | disclosed |
| US-20220125059-A1 | METHODS FOR CONTROLLING BLACK SIGATOKA IN BANANAS USING PONGAMIA OIL AND FORMULATIONS THEREOF | Terviva, Inc. (US) | 2022-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220125059-A1 | METHODS FOR CONTROLLING BLACK SIGATOKA IN BANANAS USING PONGAMIA OIL AND FORMULATIONS THEREOF | LIPA, SIGLEC7, AMY1A | CYP1A1 3611/4885CYP1B1 3816/4885CYP1A2 2668/4885 |
| US-12610971-B2 | Pongamia compositions, methods of preparing and analyzing thereof, and uses thereof | DEK, DGKG, SRMS | CYP1A1 2801/4885CYP1B1 3735/4885CYP1A2 2420/4885 |
| US-12052994-B2 | Methods for controlling black sigatoka in bananas using pongamia oil and formulations thereof | LIPA, SIGLEC7, AMY1A | CYP1A1 3611/4885CYP1B1 3816/4885CYP1A2 2668/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.